Multimedia • CME • Publishing • Courses

Peritoneal Metastases Does Not Have to be a Terminal Condition

A team of world-renowned general surgeons with extensive background and knowledge in treating peritoneal metastases have spent years developing and refining the technique of cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. They have now culled this vast knowledge into a long-awaited book and DVD set.

Paul H. Sugarbaker, MD, FACS, FRCS, Section Director of the Program in Peritoneal Surface malignancy at MedStar Washington Hosptial Center, spearheaded a team of world-class surgeons through the arduous task of massaging 30 years worth of research, data-analysis, and case studies into a finely illustrated surgical atlas and DVD set.

Educational Priorities of Cytoreductive Surgery and Perioperative Chemotherapy

Cytoreductive Surgery and Perioperative Chemotherapy for Peritoneal Surface Malignancy, provides a comprehensive overview of the data, techniques, and outcomes of this significant procedure in the treatment of peritoneal surface malignancy. Sugarbaker, who pioneered the technique, edited the text, which includes chapters by Marcello Deraco, Olivier Glehen, Cyril William Helm, David L. Morris, and Kurt Van der Speeten.

Sugarbaker wants every reader to be left with three main points:

  1. Peritoneal metastases are treatable for cure; this is not a priori a terminal condition.
  2. Complete cytoreductive surgery is the absolute criteria for long-term success in the management of peritoneal metastases.
  3. Patient selection by quantitative prognostic indicators (peritoneal cancer index, completeness of cytoreduction score, histopathologic evaluation) must be used knowledgably for best results.